Clinical Trial Update: Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients [Phase 3]

View source ↗

Summary

LG Chem's Phase 3 trial evaluating tigulixostat in gout patients with allopurinol as control has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• Tigulixostat (tigulixostat)

Snippet

Sponsor: LG Chem | Conditions: Gout, Hyperuricemia | Phase 3 | Status: COMPLETED